Russian cancer vaccine could be available in three years

Cancer vaccines are still stuck in legal procedures and production capacity issues, but if resolved, they could be launched after three years.

According to the Russian Medical and Biological Agency, the use of antigens with altered components in vaccines is not in accordance with current regulations. Scientists also face the problem of vaccine production and supply, as the country only has a few qualified facilities, for example the Blokhin Cancer Center or the Federal Center for Brain and Neurotechnology located in Moscow.

Vasily Lazarev, of the Russian Federal Medical and Biological Agency, said at the end of March that it could take up to a year to resolve all the legal and procedural issues. Once the legal pressure is reduced, the vaccine technology will attract domestic private investors, with financial support. Thanks to that, Russia can launch a cancer vaccine within three years.

For now, the Russian Federal Medical-Biological Agency has proposed allowing the production and use of drugs with modified compositions, effective in September. The agency also requires that production be carried out by the patent holder.

The news comes more than a month after Russian President Vladimir Putin announced that Russian scientists were close to creating a cancer vaccine. He did not specify what type of cancer the vaccine would target or how it would work.

Illustration of cancer vaccine. Photo: Economic Times — Illustration of cancer vaccine. Photo: *Economic Times*

In the world , there are 5 potential candidates being tested, including: V940/mRNA-4157, BNT122, TG4050, Tedopi, VB10.16. Of which, the mRNA-4157 vaccine, researched and developed by pharmaceutical companies Merck and Moderna, has been recognized by the US and European drug administration agencies, used for adjuvant treatment for patients with malignant tumors, and can be launched in 2025.

Cancer has become a constant fear for many people and many countries. Therefore, vaccines for this disease are important immunotherapy, helping to prevent and improve cancer treatment results by enhancing the body's natural defenses.

Chile (According to RT, BioSpace)

Source link